Drawing for ARIPAZINE

USPTO serial 86024678

ARIPAZINE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
PHILLIPS, WENDELL SHARMAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARIPAZINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Vorndran

CHARLES VORNDRAN PABST PATENT GROUP LLP1545 PEACHTREE ST NE STE 320ATLANTA, GA 30309-2492UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical diagnostic preparations of di-arginine piperazine, its salts, esters, isomers and related compounds for the reversal of oral direct Factor Xa and Factor Ila inhibitors and heparins when clinically indicatedABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 12, 2014MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
May 12, 2014ABN5ABANDONMENT - AFTER PUBLICATION—
May 9, 2014EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 25, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 31, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 14, 2013DOCKASSIGNED TO EXAMINER—
Aug 7, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance